We are live on ! Find out more
CCI

Columbus Circle Investors Portfolio holdings

AUM $2.28B
1-Year Est. Return 135.57%
This Fund
S&P 500
This Quarter Est. Return
+12.7%
1 Year Est. Return
+135.57%
3 Year Est. Return
+366.4%
5 Year Est. Return
+795.38%
10 Year Est. Return
–
AUM
$5.27B
AUM Growth
-$602M
Cap. Flow
-$1.31B
Cap. Flow %
-24.96%
Top 10 Hldgs %
21.09%
Holding
320
New
35
Increased
57
Reduced
81
Closed
147

Top Buys

Rank Stock Value
1
APD icon
Air Products & Chemicals
APD
+$28.2M
2
SWK icon
Stanley Black & Decker
SWK
+$27.8M
3
XPO icon
XPO
XPO
+$27.5M
4
WMT icon
Walmart Inc
WMT
+$27.2M
5
SHW icon
Sherwin-Williams
SHW
+$27M

Top Sells

Rank Stock Value
1
ISRG icon
Intuitive Surgical
ISRG
+$241M
2
CELG
Celgene Corp
CELG
+$82.3M
3
BKNG icon
Booking.com
BKNG
+$66.1M
4
ALB icon
Albemarle
ALB
+$55.9M
5
MU icon
Micron Technology
MU
+$53.9M

Sector Composition

Rank Sector Weight
1 Technology 24.27%
2 Consumer Discretionary 16.07%
3 Industrials 13.73%
4 Financials 12.44%
5 Healthcare 10.61%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
OXFD
301
DELISTED
Oxford Immunotec Global PLC Ordinary Shares
OXFD
– –
-157,123
Closed -$2.64M
WMGI
302
DELISTED
Wright Medical Group Inc
WMGI
– –
-129,846
Closed -$3.36M
AIMT
303
DELISTED
Aimmune Therapeutics
AIMT
– –
-80,818
Closed -$2M
MNTA
304
CALL
DELISTED
Momenta Pharmaceuticals, Inc.
MNTA
– –
-88,600
Closed -$1.64M
LOGM
305
DELISTED
LogMein, Inc.
LOGM
– –
-205,761
Closed -$22.6M
STML
306
DELISTED
Stemline Therapeutics, Inc.
STML
– –
-284,572
Closed -$3.16M
STML
307
PUT
DELISTED
Stemline Therapeutics, Inc.
STML
– –
-50,000
Closed -$555K
INXN
308
DELISTED
Interxion Holding N.V.
INXN
– –
-6,453
Closed -$329K
DPLO
309
DELISTED
DIPLOMAT PHARMACY, INC.
DPLO
– –
-175,336
Closed -$3.63M
BID
310
DELISTED
Sotheby's
BID
– –
-28,966
Closed -$1.34M
AET
311
DELISTED
Aetna Inc
AET
– –
-35,523
Closed -$3.71M
KTWO
312
DELISTED
K2M Group Holdings, Inc
KTWO
– –
-490,677
Closed -$10.4M
FINL
313
PUT
DELISTED
Finish Line
FINL
– –
-330,000
Closed -$3.97M
BIVV
314
CALL
DELISTED
Bioverativ Inc. Common Stock
BIVV
– –
-27,700
Closed -$1.58M
CELG
315
DELISTED
Celgene Corp
CELG
– –
-575,542
Closed -$82.3M
CELG
316
PUT
DELISTED
Celgene Corp
CELG
– –
-17,000
Closed -$2.48M
SHPG
317
DELISTED
Shire pic
SHPG
– –
-38,671
Closed -$5.92M
SHPG
318
PUT
DELISTED
Shire pic
SHPG
– –
-8,500
Closed -$1.3M
RHT
319
DELISTED
Red Hat Inc
RHT
– –
-317,114
Closed -$35.2M
VXX
320
DELISTED
iPath S&P 500 VIX Short-Term Futures ETN due 1/30/2019
VXX
– –
-15,845
Closed -$621K
9 10 11 12
13

Similar funds

SWM
SVA Wealth Management Madison, Wisconsin $1.15B AUM 22.3% 1-Year Est. Return
LCM
Lomas Capital Management New York $1.04B AUM 24.59% 1-Year Est. Return
HCMNY
Howard Capital Management (New York) New York $891M AUM 34.82% 1-Year Est. Return
BII
Bainco International Investors Boston, Massachusetts $873M AUM 30.2% 1-Year Est. Return
HCM
Horan Capital Management Hunt Valley, Maryland $794M AUM 30.86% 1-Year Est. Return
DBC
Deep Basin Capital Stamford, Connecticut $739M AUM 4.75% 1-Year Est. Return
DK
Darrell & King Charlottesville, Virginia $633M AUM 49.4% 1-Year Est. Return
AVAX
Atlas Venture Associates XI Cambridge, Massachusetts $631M AUM

Columbus Circle Investors's Q4 2017 Portfolio in Review

As of Q4 2017, Columbus Circle Investors held 320 positions worth $5.27B, down 10% from $5.87B the previous quarter. Its ten largest holdings account for 21% of the portfolio.

Columbus Circle Investors withdrew a net $1.31B in Q4 2017, closing 147 positions and reducing 81 holdings. Its most notable exit was Celgene Corp, an estimated $82.3M position sold in full.

By sector, the portfolio is most concentrated in Technology at 24% of assets, down from 25% a quarter earlier, followed by Consumer Discretionary and Industrials.

Against the trend, Columbus Circle Investors opened a new position in Air Products & Chemicals worth $29M.

  • Columbus Circle Investors's largest Q4 2017 buy was Air Products & Chemicals: 176,941 shares worth $29M.
  • Columbus Circle Investors added most to Stanley Black & Decker in Q4 2017, an estimated $27.8M increase.
  • Columbus Circle Investors's biggest Q4 2017 reduction was Intuitive Surgical, cutting an estimated $241M.
  • Columbus Circle Investors fully exited Celgene Corp in Q4 2017, selling an estimated $82.3M.
  • Columbus Circle Investors's ten largest holdings make up 21% of its $5.27B portfolio in Q4 2017.
  • Columbus Circle Investors opened 35 new positions and closed 147 in Q4 2017.
  • Columbus Circle Investors's portfolio value fell 10% quarter-over-quarter to $5.27B.

Based on Columbus Circle Investors's 13F filing for Q4 2017, filed 2 Feb 2018.